Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks is a research paper published in Journal of Clinical Medicine (2020). On theSindex it has a DataRank of 0.510. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Università degli Studi di Sassari
Grant: SICT Project
Italian Ministry of Education, University and Research (MIUR)
Grant: PRIN 2017Z3N3YC
FWCI
2.36
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals